6/24/2022  9:49:20 PM Chg. +1.280 Volume Bid9:59:58 PM Ask9:59:58 PM Market Capitalization Dividend Y. P/E Ratio
47.290EUR +2.78% 13,600
Turnover: 638,892.390
47.120Bid Size: 260 47.410Ask Size: 260 13.91 bill.EUR 2.84% 14.35

Business description

Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.

Management board & Supervisory board

Carla Kriwet (ab 1.01.2023)
Management board
Helen Giza, Dr. Katarzyna Mazur-Hofsäß, Frank Maddux, MD, William Valle
Supervisory board
Dr. Dieter Schenk, Dr. Dorothea Wenzel, Gregory Sorensen, MD, Pascale Witz, Prof. Dr. Gregor Zünd, Rolf A. Classon

Company data

Name: Fresenius Medical Care AG & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-609-0
Fax: +49-6172-609-2301
E-mail: -
Internet: www.fmc-ag.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 44.91%
IPO date: 10/2/1996

Investor relations

Name: Dr. Dominic Heger
IR phone: +49-6172-609-2601
IR Fax: -
IR e-mail: ir@fmc-ag.com

Company calendar

CW 33 | 8/9/2022 Interim Report 2nd Quarter/6 Months
CW 46 | 11/9/2022 Interim Report 3rd Quarter/9 Months

Main Shareholders

Fresenius SE & Co. KGaA
Thornburg Investment Management Inc.
BlackRock, Inc.
Artisan Partners Asset Management Inc.
Richard Pzena
Harris Associates L.P.
FIL Limited
Norges Bank